Nitrous oxide

Description

Nitrous Oxide, with a Chemical Abstracts Service (CAS) number of 10024-97-2, is a non-flammable gas classified as an oxidizer (5.1). It is available in various container sizes, including 2 lb, 7 lb, 20 lb, 30 lb, and 56 lb.

Uses and Indications

This drug is indicated for use in medical settings where nitrous oxide is administered. The administration of nitrous oxide may be hazardous or contraindicated in certain situations. It is essential that this drug is used only by or under the supervision of a licensed practitioner who is experienced in the use and administration of nitrous oxide.

There are no specific teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For administration, Nitrous Oxide is to be used exclusively by or under the supervision of a licensed practitioner who is experienced in its use and administration.

The route of administration is via respiratory inhalation. The active ingredient is Nitrous Oxide, provided in a strength of 990 mL per 1 L.

Healthcare professionals should ensure that the administration is conducted in a controlled environment, adhering to established protocols for inhalation therapy. Proper equipment and monitoring should be utilized to ensure patient safety and effective delivery of the gas.

Contraindications

There are no specific contraindications identified for the use of this product. However, it is advised to avoid contact with eyes, skin, or clothing, as exposure may lead to irritation. Additionally, the product label should not be removed, as it contains important information regarding the product's use and safety.

Warnings and Precautions

Administration of nitrous oxide may pose significant hazards and is contraindicated in certain situations. It is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion, potentially leading to rapid suffocation. Additionally, nitrous oxide can induce anesthetic effects and may cause frostbite upon contact with skin or mucous membranes.

To ensure safe handling and administration, it is imperative to avoid inhalation of the gas. Adequate ventilation must be maintained during use, and all oil and grease should be kept away from the equipment. Only utilize apparatus that has been cleaned for oxygen and is rated for the appropriate cylinder pressure. Care should be taken to prevent liquid from coming into contact with the eyes, skin, or clothing. The temperature of the cylinder must not exceed 52˚C (125˚F). When opening the valve, it should be done slowly, and the valve must be closed after each use and when the cylinder is empty. A backflow preventive device should be employed in the piping system, and all procedures should be conducted in accordance with the Material Safety Data Sheet (MSDS).

Nitrous oxide should only be administered by or under the supervision of a licensed practitioner who possesses experience in its use. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

In the event of inhalation, it is critical to remove the individual to fresh air immediately. If the person is not breathing, artificial respiration should be provided. If breathing difficulties arise, supplemental oxygen should be administered, and a physician should be contacted without delay. In cases of frostbite, prompt medical treatment is essential.

No specific laboratory tests are required for the safe use of nitrous oxide. However, practitioners should remain vigilant and monitor patients closely for any adverse effects during administration.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this product. Serious adverse reactions include rapid suffocation, which is a critical concern and warrants immediate medical attention. Additionally, patients may experience anesthetic effects, which can impact their overall sensory perception and response to stimuli.

Common adverse reactions reported include frostbite, a condition that can occur under specific circumstances related to the product's use. It is essential for healthcare providers to monitor patients closely for these reactions and to educate them on the potential risks involved.

Given the severity of some of these reactions, it is crucial for patients to be aware of the signs and symptoms associated with rapid suffocation and to seek prompt medical assistance if they occur.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of nitrous oxide may pose hazards or be contraindicated in pediatric patients. It is essential that nitrous oxide is used only by or under the supervision of a licensed practitioner who has experience in its use and administration. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions, particularly when treating children.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Administration of nitrous oxide may pose potential risks during pregnancy and is contraindicated in this population. Healthcare professionals should exercise caution when considering the use of nitrous oxide in pregnant patients due to the lack of sufficient data on its safety and potential fetal impacts. It is essential to evaluate the risks versus benefits in each case and to consider alternative analgesic options that may be safer for use during pregnancy. Women of childbearing potential should be informed of these risks and advised to discuss any concerns with their healthcare provider.

Lactation

There is no specific information regarding the use of Nitrous Oxide in lactating mothers or any lactation considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers about the use of this agent. The potential effects on breastfed infants remain undetermined due to the absence of relevant studies.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert for Nitrous Oxide. Therefore, healthcare professionals should exercise caution when administering this agent to individuals with reduced kidney function, as the absence of data limits the ability to make informed decisions regarding its use in this population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions in the patient's medical record to ensure continuity of care and facilitate any necessary follow-up.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has revealed the following adverse reactions reported voluntarily or through surveillance programs: hypoxia, neurological effects, nausea and vomiting, headache, dizziness, altered mental status, increased intracranial pressure, cardiovascular effects including hypotension and bradycardia, respiratory depression, and frostbite injuries resulting from improper handling of the gas.

Patient Counseling

Healthcare providers should advise patients that the administration of nitrous oxide may pose hazards or be contraindicated in certain situations. It is essential that nitrous oxide is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must communicate the following warnings to patients: nitrous oxide is a high-pressure oxidizing liquid and gas that vigorously accelerates combustion, can cause rapid suffocation, and may induce anesthetic effects. Additionally, patients should be made aware that exposure to nitrous oxide can lead to frostbite.

Patients should be instructed to avoid breathing the gas directly and to ensure that the area is adequately ventilated during use. It is crucial to keep oil and grease away from the equipment and to use only apparatus that has been cleaned for oxygen and is rated for cylinder pressure. Patients should be cautioned against allowing liquid nitrous oxide to come into contact with their eyes, skin, or clothing. Furthermore, the cylinder temperature should not exceed 52˚C (125˚F), and the valve should be opened slowly. After each use and when the cylinder is empty, the valve should be closed.

Healthcare providers should emphasize the importance of using a backflow preventive device in the piping and adhering to the guidelines outlined in the Material Safety Data Sheet (MSDS). In the event of inhalation, patients should be instructed to move to fresh air immediately. If the patient is not breathing, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. It is imperative to call a physician in such cases. In instances of frostbite, patients should seek medical treatment without delay.

Storage and Handling

The product is supplied in a cylinder format, which requires careful handling and storage to ensure safety and efficacy. It is essential to store and use the product in an area with adequate ventilation to prevent the accumulation of potentially harmful gases.

To maintain the integrity of the cylinder, it is crucial to keep oil and grease away from the gas. The equipment used with this product must be specifically cleaned for oxygen use and rated for the appropriate cylinder pressure.

The temperature of the cylinder must not exceed 52˚C (125˚F) to prevent any risk of degradation or failure. When operating the cylinder, the valve should be opened slowly to control the release of gas. After each use, and when the cylinder is empty, the valve must be closed to ensure safety. Additionally, a backflow preventive device should be utilized in the piping to prevent any reverse flow of gas.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Quality Air Products Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)